Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $78.7 million.

  • Veracyte's Shares Outstanding (Weighted Average) rose 222.19% to $78.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.7 million, marking a year-over-year increase of 222.19%. This contributed to the annual value of $76.5 million for FY2024, which is 528.67% up from last year.
  • Per Veracyte's latest filing, its Shares Outstanding (Weighted Average) stood at $78.7 million for Q3 2025, which was up 222.19% from $78.4 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Shares Outstanding (Weighted Average) ranged from a high of $78.7 million in Q3 2025 and a low of $63.3 million during Q1 2021
  • In the last 5 years, Veracyte's Shares Outstanding (Weighted Average) had a median value of $72.5 million in 2023 and averaged $72.9 million.
  • In the last 5 years, Veracyte's Shares Outstanding (Weighted Average) skyrocketed by 3406.34% in 2021 and then skyrocketed by 132.78% in 2023.
  • Veracyte's Shares Outstanding (Weighted Average) (Quarter) stood at $67.9 million in 2021, then grew by 5.39% to $71.5 million in 2022, then rose by 1.53% to $72.6 million in 2023, then rose by 5.29% to $76.5 million in 2024, then increased by 2.93% to $78.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $78.7 million in Q3 2025, compared to $78.4 million in Q2 2025 and $78.0 million in Q1 2025.